CK 204-933

has biochemical, behavioral & endocrine effects; structure given in first source

Also Known As:

9,10-didehydro-2,6-dimethyl-8-((2-pyridinylthio)methyl)ergoline; CK-204933; Ergoline, 9,10-didehydro-2,6-dimethyl-8-((2-pyridinylthio)methyl)-, (8beta)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Ergot Alkaloids: 208
    - Ergolines: 109
      - CK 204-933: 1
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Ergolines: 109
      - CK 204-933: 1

Related Diseases

1.	Brain Diseases (Brain Disorder) 01/01/1987 - "Based on these properties it is suggested that CK 204-933 could be of therapeutic value in brain diseases associated with disturbances of monoaminergic neurotransmission."